Target expression details
| Target General Information | |||||
|---|---|---|---|---|---|
| Target ID | T97353 | ||||
| Target Name | Integrin alpha-2/beta-1 | ||||
| Synonyms | ITGB1 | ||||
| Target Type | Clinical Trial | ||||
| Gene Name | ITGB1 | ||||
| Biochemical Class | Integrin | ||||
| UniProt ID | ITB1_HUMAN | ||||
| Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
| Disease | Multiple sclerosis | ||||
| Example drug | Vatelizumab | Phase 2 | [524887], [1572592] | ||
| Tissue | Spinal cord | ||||
| Level of differential expression between the patients in the disease section of the tissue and the patients in the normal section of the tissue adjacent to the disease section | Fold-change: 0.06 Z-score: 0.22 P-value: 9.19E-01 |
||||
|
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles of the patients in the normal section of the tissue adjacent to the disease section
|
|||||
| Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
|
|||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.